Trial Profile
Safety and efficacy of elisidepsin in combination with carboplatin and gemcitabine in patients with advanced malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Elisidepsin (Primary) ; Carboplatin; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- 15 Oct 2015 New trial record